Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Finished Goods: 2015-2016

  • Avadel Pharmaceuticals' Finished Goods was N/A to $3.3 million in Q2 2016 from the same period last year, while for Jun 2016 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2015, which is N/A change from last year.
  • Avadel Pharmaceuticals' Finished Goods amounted to $3.3 million in Q2 2016, which was up 28.88% from $2.5 million recorded in Q4 2015.
  • Avadel Pharmaceuticals' 5-year Finished Goods high stood at $3.3 million for Q2 2016, and its period low was $2.5 million during Q4 2015.
  • In the last 2 years, Avadel Pharmaceuticals' Finished Goods had a median value of $2.9 million in 2015 and averaged $2.9 million.